23andMe customers requesting deletion of genetic data

Nearly 2 million 23andMe customers have requested deletion of their genetic data following bankruptcy and pending sale to Regeneron. Regeneron plans to use the data for drug discovery while upholding privacy practices. States have filed a lawsuit against the sale.

Challenging of 23andMe's CEO on Transgender Pronouns

Rep. Brandon Gill challenges 23andMe's former CEO Anne Wojcicki about transgender pronouns used in a social media post, she admits she is not 'up to speed' on the topic. Gill questions the company's stance on pronouns and transgender issues during a hearing.

Lawsuit to Block Sale of 23andMe Genetic Data Without Consent

27 states and D.C. filed a lawsuit to block the sale of personal genetic data by 23andMe without customer consent as a biotech company seeks to buy the struggling firm in bankruptcy court.

Potential Impact of 23andMe Sale on Cold-Case Investigations

The bankruptcy filing of genetic testing company 23andMe has sparked the possibility of aiding cold-case investigations by selling its data to law enforcement. The company has resisted law enforcement requests in the past but could potentially provide valuable genetic information for solving unsolved cases.